|
MechanismENaCα inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseClinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with AeroNeph Therapeutics
0 Patents (Medical) associated with AeroNeph Therapeutics
100 Deals associated with AeroNeph Therapeutics
100 Translational Medicine associated with AeroNeph Therapeutics